{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T05:02:30Z","timestamp":1779944550011,"version":"3.53.1"},"reference-count":89,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bacteroides 2 (Bact2) is a dysbiotic enterotype often associated with susceptibility to developing diseases such as inflammatory bowel disease (IBD). Carriers of Bact2 are found to be less responsive to therapeutic treatments like vedolizumab. This enterotype is characterised by a large amount of Bacteroides, low diversity in bacteria, fewer butyrate-producing species, and generally a low abundance of microbes in the gut. However, it remains unclear whether this dysbiosis contributes to IBD pathology or if it is merely a result of inflammation in the gut. Due to its ability to influence treatment responses, it is crucial to understand the molecular mechanisms behind this enterotype, as well as the effect of diet on this dysbiosis. A high concentration of pro-inflammatory cytokine IL-1\u03b2 was found in the faecal water of Bact2 patients, as well as an abundance of conjugated bile acids, whereas butyrate was found in decreased amounts. Through the consumption of a less industrialised diet, it could be possible to shift away from a dysbiotic enterotype like Bact2. This includes the consumption of whole-grain carbohydrates to increase the growth of butyrate-producers and maintaining a low-fat diet to decrease bile acid production.<\/jats:p>","DOI":"10.3390\/ijms27114754","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T14:10:22Z","timestamp":1779718222000},"page":"4754","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Review on the Molecular Dynamics of Enterotype Bacteroides 2 in Relation to Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0638-4592","authenticated-orcid":false,"given":"Thuy Mi","family":"Nguyen","sequence":"first","affiliation":[{"name":"Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Center (UMC), Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, Meibergdreef 69, 1105 BK Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anje A. te","family":"Velde","sequence":"additional","affiliation":[{"name":"Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Center (UMC), Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), University of Amsterdam, Meibergdreef 69, 1105 BK Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/1751-2980.12795","article-title":"Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease","volume":"20","author":"Weng","year":"2019","journal-title":"J. Dig. Dis."},{"key":"ref_3","first-page":"411","article-title":"Inflammatory Bowel Disease","volume":"50","author":"Bruner","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: Pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"103717","DOI":"10.1016\/j.autrev.2024.103717","article-title":"Intestinal mucus barrier: A potential therapeutic target for IBD","volume":"24","author":"Qiao","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00054725-200307000-00001","article-title":"Inducible and constitutive beta-defensins are differentially expressed in Crohn\u2019s disease and ulcerative colitis","volume":"9","author":"Wehkamp","year":"2003","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2982.2012.01921.x","article-title":"Intestinal barrier function in health and gastrointestinal disease","volume":"24","author":"Camilleri","year":"2012","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ni1511","article-title":"Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17\u2013producing T cell responses","volume":"8","author":"Denning","year":"2007","journal-title":"Nat. Immunol."},{"key":"ref_10","first-page":"718617","article-title":"Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks","volume":"2012","author":"Cerar","year":"2012","journal-title":"BioMed Res. Int."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Johansson, M.E.V., Gustafsson, J.K., Sj\u00f6berg, K.E., Petersson, J., Holm, L., Sj\u00f6vall, H., and Hansson, G.C. (2010). Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012238"},{"key":"ref_12","first-page":"342637","article-title":"Animal Models of Colitis-Associated Carcinogenesis","volume":"2011","author":"Kanneganti","year":"2011","journal-title":"J. BioMed Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bresser, L.R.F., de Goffau, M.C., Levin, E., and Nieuwdorp, M. (2022). Gut Microbiota in Nutrition and Health with a Special Focus on Specific Bacterial Clusters. Cells, 11.","DOI":"10.3390\/cells11193091"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41564-019-0483-9","article-title":"Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC\/IBD diagnoses","volume":"4","author":"Sabino","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.gastro.2023.11.304","article-title":"Dysbiosis and Associated Stool Features Improve Prediction of Response to Biological Therapy in Inflammatory Bowel Disease","volume":"166","author":"Caenepeel","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity","volume":"7","author":"Mills","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.chom.2025.09.010","article-title":"A Bacteroides fragilis protease activates host PAR2 to induce intestinal pain and inflammation","volume":"33","author":"Lakemeyer","year":"2025","journal-title":"Cell Host Microbe"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liu, L., Xu, M., Lan, R., Hu, D., Li, X., Qiao, L., Zhang, S., Lin, X., Yang, J., and Ren, Z. (2022). Bacteroides vulgatus attenuates experimental mice colitis through modulating gut microbiota and immune responses. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1036196"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","article-title":"Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p","volume":"161","author":"Cao","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"wrae146","DOI":"10.1093\/ismejo\/wrae146","article-title":"Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria","volume":"18","author":"Zhang","year":"2024","journal-title":"ISME J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"G607","DOI":"10.1152\/ajpgi.00303.2023","article-title":"Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii served as key components of fecal microbiota transplantation to alleviate colitis","volume":"326","author":"Xu","year":"2024","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"107183","DOI":"10.1016\/j.intimp.2020.107183","article-title":"Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4+T cell homeostasis","volume":"90","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.chom.2019.04.002","article-title":"Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis","volume":"25","author":"Brown","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13099-025-00730-3","article-title":"Bacteroides- and Prevotella-enriched gut microbial clusters associate with metabolic risks","volume":"17","author":"Bah","year":"2025","journal-title":"Gut Pathog."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S-565\u2013S-566","DOI":"10.1016\/S0016-5085(24)01772-4","article-title":"Sa1887 Is Diversity Important in the Gut Microbiome at IBD Onset? A Systematic Review of the Literature and Meta-Analysis of Alpha-Diversity Data","volume":"166","author":"Rimmer","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e00616-22","DOI":"10.1128\/spectrum.00616-22","article-title":"Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission","volume":"10","author":"Pisani","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e01277-20","DOI":"10.1128\/msystems.01277-20","article-title":"Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting","volume":"6","author":"Sarrabayrouse","year":"2021","journal-title":"mSystems"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e01894-24","DOI":"10.1128\/spectrum.01894-24","article-title":"The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab","volume":"13","author":"Eriksson","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kushkevych, I., Mart\u00ednkov\u00e1, K., V\u00edt\u011bzov\u00e1, M., and Rittmann, S.K.M.R. (2021). Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Colitis Studies. J. Clin. Med., 10.","DOI":"10.3390\/jcm10030462"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Campmans-Kuijpers, M.J.E., and Dijkstra, G. (2021). Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID). Nutrients, 13.","DOI":"10.3390\/nu13041067"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.3748\/wjg.v25.i18.2204","article-title":"Characteristics of mucosa-associated gut microbiota during treatment in Crohn\u2019s disease","volume":"25","author":"He","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2424913","DOI":"10.1080\/19490976.2024.2424913","article-title":"Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: An in vitro analysis","volume":"16","author":"Poppe","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature11225","article-title":"Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10\u2212\/\u2212 mice","volume":"487","author":"Devkota","year":"2012","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Aggeletopoulou, I., Kalafateli, M., Tsounis, E.P., and Triantos, C. (2024). Exploring the role of IL-1\u03b2 in inflammatory bowel disease pathogenesis. Front. Med., 11.","DOI":"10.3389\/fmed.2024.1307394"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1084\/jem.20111703","article-title":"Microbiota-induced IL-1\u03b2, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine","volume":"209","author":"Shaw","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, L., Ruan, G., Cheng, Y., Yi, A., Chen, D., and Wei, Y. (2023). The role of Th17 cells in inflammatory bowel disease and the research progress. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1055914"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.20111453","article-title":"IL-1\u03b2 mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells","volume":"209","author":"Coccia","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ibd.21677","article-title":"Functional Relevance of T Helper 17 (Th17) Cells and the IL-17 Cytokine Family in Inflammatory Bowel Disease","volume":"18","author":"Hundorfean","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.4049\/jimmunol.178.7.4641","article-title":"IL-1\u03b2 Causes an Increase in Intestinal Epithelial Tight Junction Permeability","volume":"178","author":"Ma","year":"2007","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Kaminsky, L.W., Al-Sadi, R., and Ma, T.Y. (2021). IL-1\u03b2 and the Intestinal Epithelial Tight Junction Barrier. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.767456"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"55506","DOI":"10.1074\/jbc.M408822200","article-title":"A Differentiation-dependent Splice Variant of Myosin Light Chain Kinase, MLCK1, Regulates Epithelial Tight Junction Permeability","volume":"279","author":"Clayburgh","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Busch, M., Ramachandran, H., Wahle, T., Rossi, A., and Schins, R.P.F. (2022). Investigating the Role of the NLRP3 Inflammasome Pathway in Acute Intestinal Inflammation: Use of THP-1 Knockout Cell Lines in an Advanced Triple Culture Model. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.898039"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mao, L., Kitani, A., Strober, W., and Fuss, I.J. (2018). The Role of NLRP3 and IL-1\u03b2 in the Pathogenesis of Inflammatory Bowel Disease. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02566"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10620-024-08523-5","article-title":"DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering","volume":"70","author":"Sandys","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"115610","DOI":"10.1016\/j.intimp.2025.115610","article-title":"Phytosphingosine alleviates DSS-induced colitis by regulating the gut microbiota and inflammatory responses","volume":"166","author":"Shan","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"18558","DOI":"10.1038\/s41598-024-62463-8","article-title":"Sustained mucosal colonization and fecal metabolic dysfunction by Bacteroides associates with fecal microbial transplant failure in ulcerative colitis patients","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1968257","DOI":"10.1080\/19490976.2021.1968257","article-title":"Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease","volume":"13","author":"Li","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1002\/ctm2.334","article-title":"Cyclosporine modulates neutrophil functions via the SIRT6\u2013HIF-1\u03b1\u2013glycolysis axis to alleviate severe ulcerative colitis","volume":"11","author":"Lu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lin, E.Y., Lai, H.J., Cheng, Y.K., Leong, K.Q., Cheng, L.C., Chou, Y.C., Peng, Y.C., Hsu, Y.H., and Chiang, H.S. (2020). Neutrophil Extracellular Traps Impair Intestinal Barrier Function during Experimental Colitis. Biomedicines, 8.","DOI":"10.20944\/preprints202007.0130.v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"166984","DOI":"10.1016\/j.bbadis.2023.166984","article-title":"Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2\/GPX4 signal pathway and improving intestinal barrier","volume":"1870","author":"Chen","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2470958","DOI":"10.1080\/07853890.2025.2470958","article-title":"Sodium butyrate alleviates DSS-induced inflammatory bowel disease by inhibiting ferroptosis and modulating ERK\/STAT3 signaling and intestinal flora","volume":"57","author":"Liu","year":"2025","journal-title":"Ann. Med."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kriaa, A., Mariaule, V., Jablaoui, A., Rhimi, S., Mkaouar, H., Hernandez, J., Korkmaz, B., Lesner, A., Maguin, E., and Aghdassi, A. (2022). Bile Acids: Key Players in Inflammatory Bowel Diseases?. Cells, 11.","DOI":"10.3390\/cells11050901"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Shi, L., Jin, L., and Huang, W. (2023). Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases. Cells, 12.","DOI":"10.3390\/cells12141888"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Fiorucci, S., Biagioli, M., Marchian\u00f2, S., Zampella, A., and Distrutti, E. (2026). Secondary bile acids as immune and metabolic mediators. Trends Immunol.","DOI":"10.1016\/j.it.2025.12.008"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jare.2024.11.003","article-title":"Biological functions and pharmacological behaviors of bile acids in metabolic diseases","volume":"75","author":"Zhuang","year":"2025","journal-title":"J. Adv. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D Receptor As an Intestinal Bile Acid Sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/j.2040-4603.2020.tb00108.x","article-title":"Intestinal Absorption of Bile Acids in Health and Disease","volume":"10","author":"Ticho","year":"2019","journal-title":"Compr. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1949095","DOI":"10.1080\/19490976.2021.1949095","article-title":"Effect of different bile acids on the intestine through enterohepatic circulation based on FXR","volume":"13","author":"Xiang","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_61","first-page":"851","article-title":"Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-\u03baB signaling in the intestine","volume":"1812","author":"Gadaleta","year":"2011","journal-title":"Transl. Nucl. Recept. Health Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Zhou, M., Wang, D., Li, X., Cao, Y., Yi, C., Wiredu Ocansey, D.K., Zhou, Y., and Mao, F. (2022). Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1016836"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"24741","DOI":"10.1021\/acs.jafc.5c07236","article-title":"Ovalbumin Peptides Restore Intestinal Barrier Integrity via Gut\u2013Liver Axis Modulation of Bile Salt Hydrolase and Bile Acids Crosstalk","volume":"73","author":"Yang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2018.08.022","article-title":"FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid","volume":"155","author":"Friedman","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/j.1476-5381.2011.01481.x","article-title":"Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice","volume":"164","author":"Fiorucci","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Anderson, K.M., and Gayer, C.P. (2021). The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. Cells, 10.","DOI":"10.3390\/cells10113206"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10620-020-06208-3","article-title":"Deoxycholic acid-induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal inflammation","volume":"66","author":"Xu","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lu, G., Zhang, S., Wang, R., Wu, X., Chen, Y., Wen, Q., Cui, B., Zhang, F., and Li, P. (2025). Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: Results of microbiota and metabolites from two cohort studies. BMC Med., 23.","DOI":"10.1186\/s12916-025-04353-y"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"110317","DOI":"10.1016\/j.foodres.2021.110317","article-title":"In vitro colonic fermentation profiles and microbial responses of propionylated high-amylose maize starch by individual Bacteroides-dominated enterotype inocula","volume":"144","author":"Xie","year":"2021","journal-title":"Food Res. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"16088","DOI":"10.1038\/nmicrobiol.2016.88","article-title":"Species\u2013function relationships shape ecological properties of the human gut microbiome","volume":"1","author":"Falony","year":"2016","journal-title":"Nat. Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-food-030117-012830","article-title":"Diet, Microbiota, and Metabolic Health: Trade-Off Between Saccharolytic and Proteolytic Fermentation","volume":"9","author":"Korpela","year":"2018","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jgh.12694","article-title":"Association between specific mucosa-associated microbiota in Crohn\u2019s disease at the time of resection and subsequent disease recurrence: A pilot study","volume":"30","author":"Kang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1017\/S1751731113000062","article-title":"Impact of dietary protein on microbiota composition and activity in the gastrointestinal tract of piglets in relation to gut health: A review","volume":"7","author":"Rist","year":"2013","journal-title":"Animal"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Stummer, N., Feichtinger, R.G., Weghuber, D., Kofler, B., and Schneider, A.M. (2023). Role of Hydrogen Sulfide in Inflammatory Bowel Disease. Antioxidants, 12.","DOI":"10.3390\/antiox12081570"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Alili, R., Belda, E., Fabre, O., Pelloux, V., Giordano, N., Legrand, R., Bel Lassen, P., Swartz, T.D., Zucker, J.D., and Cl\u00e9ment, K. (2022). Characterization of the Gut Microbiota in Individuals with Overweight or Obesity during a Real-World Weight Loss Dietary Program: A Focus on the Bacteroides 2 Enterotype. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010016"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/nqaa254","article-title":"Exploring changes in the human gut microbiota and microbial-derived metabolites in response to diets enriched in simple, refined, or unrefined carbohydrate-containing foods: A post hoc analysis of a randomized clinical trial","volume":"112","author":"Faits","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1111\/1541-4337.12728","article-title":"Health benefits of whole grain: Effects on dietary carbohydrate quality, the gut microbiome, and consequences of processing","volume":"20","author":"Seal","year":"2021","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3168\/jds.2018-15226","article-title":"Low-fat yogurt alleviates the pro-inflammatory cytokine IL-1\u03b2-induced intestinal epithelial barrier dysfunction","volume":"102","author":"Zhai","year":"2019","journal-title":"J. Dairy Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e70989","DOI":"10.1002\/fsn3.70989","article-title":"Donkey Milk Improves Dextran Sulfate Sodium-Induced Ulcerative Colitis by Protecting Gut Barrier Function, Inhibiting the TLR4\/MyD88\/NF-\u03baB Signaling Pathway, and Modulating Gut Microbiota","volume":"13","author":"Yang","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Khan, M.Z., Chen, W., Li, M., Ren, W., Huang, B., Kou, X., Ullah, Q., Wei, L., Wang, T., and Khan, A. (2024). Is there sufficient evidence to support the health benefits of including donkey milk in the diet?. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1404998"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","article-title":"Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats","volume":"141","author":"Islam","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Aasmets, O., Krigul, K.L., and Org, E. (2022). Evaluating the clinical relevance of the enterotypes in the Estonian microbiome cohort. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.917926"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Di Pierro, F. (2021). A Possible Perspective about the Compositional Models, Evolution, and Clinical Meaning of Human Enterotypes. Microorganisms, 9.","DOI":"10.3390\/microorganisms9112341"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.gpb.2018.02.004","article-title":"Stereotypes About Enterotype: The Old and New Ideas","volume":"17","author":"Cheng","year":"2019","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40168-018-0608-z","article-title":"Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children","volume":"7","author":"Zhong","year":"2019","journal-title":"Microbiome"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.1000097107","article-title":"Composition, variability, and temporal stability of the intestinal microbiota of the elderly","volume":"108","author":"Claesson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-020-2269-x","article-title":"Statin therapy is associated with lower prevalence of gut microbiota dysbiosis","volume":"581","author":"Falony","year":"2020","journal-title":"Nature"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4754\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:11:08Z","timestamp":1779941468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":89,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114754"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114754","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]}}}